Key points are not available for this paper at this time.
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTp53 Activation by Small Molecules: Application in OncologyLyubomir T. VassilevView Author Information Discovery Oncology, Roche Research Center, Hoffmann-La Roche Inc., Nutley, New Jersey 07110 Cite this: J. Med. Chem. 2005, 48, 14, 4491–4499Publication Date (Web):June 18, 2005Publication History Received20 January 2005Published online18 June 2005Published inissue 1 July 2005https://pubs.acs.org/doi/10.1021/jm058174khttps://doi.org/10.1021/jm058174kreview-articleACS PublicationsCopyright © 2005 American Chemical SocietyRequest reuse permissionsArticle Views2294Altmetric-Citations138LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antagonists,Cancer,Cancer therapy,Cells,Peptides and proteins Get e-Alerts
Lyubomir T. Vassilev (Sat,) studied this question.